Humatica advises Baird Capital on its investment in UGSI

ndetails

Humatica, the leading private equity specialist advisor for portfolio company organisational effectiveness, has advised Baird Capital’s private equity team on its recent investment in UGSI. UGSI is a leading provider of Water Quality Management Solutions and Chemical Feed Systems to the municipal water and wastewater utility markets. Humatica was engaged by Baird Capital to provide Organisational Due Diligence advice for this transaction.

The investment will enable the company to fuel continued growth due to the increasing prevalence of municipal water quality issues driven by climate change, increasing population density, aging infrastructure and resource scarcity.

Marcel Bättig, Humatica Partner, commented:

“Besides providing the encompassing organizational due diligence Humatica is often retained for, we also partnered with Baird to think through organizational development options for key management talent for UGSI and the future-state operating model. This to help ensure that Baird and the management team collaborate effectively from Day 1.”

Rob Ospalik, Baird Capital Partner, added:

“Humatica once again proved to be integral in carrying out the organizational due diligence on this transaction. We have partnered on several transactions over the years, and their expertise in the area of organizational effectiveness is second to none.”

The Humatica team was led by Marcel Bättig, Partner.

 

Related News

Humatica announces promotions in London
28 Oct, 2025 By Humatica

Humatica announces promotions in London

Humatica is pleased to announce three promotions in its London office. Stephanie Hilders and Richard Breitschwerdt have been promoted to Consultant, and Juan Zapardiel has…

Read more arrowicon
The Resilience Premium: How Great CEOs Turn Adversity into Alpha
21 Aug, 2025 By Humatica

The Resilience Premium: How Great CEOs Turn Adversity into Alpha

Firsthand strategies from portfolio company CEO’s who outperformed in uncertain times Portfolio company leaders are facing bigger challenges than ever before. Unprecedented macro-headwinds from increased…

Read more arrowicon
Humatica Delivers Continued Growth in 1H 2025 and Wins Top Industry Honors
10 Jul, 2025 By Humatica

Humatica Delivers Continued Growth in 1H 2025 and Wins Top Industry Honors

Zurich, 10 July 2025 – Humatica posted further growth in the first half of 2025, topping record same-period growth last year. Consulting fee revenues increased…

Read more arrowicon